ABVC BioPharma(ABVC) - 2024 Q3 - Quarterly Results

Exhibit 99.1 ABVC BioPharma Inc. Reports Q3 2024 Financial Results and Operational Milestones ● ABVC BioPharma Achieved its First Operational Profit, with a 102% Improvement over the Third Quarter of Last Year. ● Incremental Payments Received based on Executed Global Licensing Agreements that could provide up to $292 million in income ● Received Cash Milestone Incomes of $496,000 for the nine months ended September 30, 2024 Fremont, CA (November 14, 2024) – ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-st ...